VRCA

Verrica Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↑ 8/10
  • Momentum↓ 4/10
Verrica Pharmaceuticals sales and earnings growth
VRCA Growth
Good
  • Revenue Y/Y↑ 234.73%
  • EPS Y/Y↑ 84.71%
  • FCF Y/Y↑ 51.21%
Verrica Pharmaceuticals gross and profit margin trends
VRCA Profitability
Good
  • Gross margin ↑ 91.40%
  • EPS margin↓ -84.40%
  • ROIC↓ -62.50%
Verrica Pharmaceuticals net debt vs free cash flow
VRCA Risk
Great
  • Debt / Equity↓ -2.1
  • Debt / FCF↓ 0.5
  • Interest coverage↓ -2.0

Verrica Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗